CRY CryoLife Inc

ATLANTA, Jan. 2 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE:CRY), a biomaterials, medical device and tissue processing company, announced today that it is scheduled to participate in the OneMedPlace Finance Forum, January 7-8, 2008 at the Sir Francis Drake Hotel in Union Square, San Francisco. D. Ashley Lee, executive vice president, chief operating officer and chief financial officer of CryoLife, Inc., will present on Tuesday, January 8th at 5:00 p.m. Pacific Time. Information about the OneMedPlace Finance Forum may be found at http://www.onemedplace.com/meeting. About CryoLife Founded in 1984, CryoLife, Inc. is a leader in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries throughout the United States and Canada. The Company's BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. BioGlue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. The Company also distributes the CryoLife-O'Brien(R) stentless porcine heart valve, which is CE marked for distribution within the European Community. For additional information about the Company, visit CryoLife's Web Site: http://www.cryolife.com/. Media Contacts: D. Ashley Lee Katie Brazel Executive Vice President, Fleishman Hillard Chief Financial Officer and Phone: 404-739-0150 Chief Operating Officer Phone: 770-419-3355 DATASOURCE: CryoLife, Inc. CONTACT: D. Ashley Lee, Executive Vice President, Chief Financial Officer and Chief Operating Officer, CryoLife, Inc., +1-770-419-3355; or Katie Brazel of Fleishman Hillard, +1-404-739-0150, for CryoLife, Inc. Web site: http://www.cryolife.com/ http://www.onemedplace.com/meeting

Copyright